GUTS 8-K 2026-11-06

FRACTYL HEALTH, INC. (GUTS) 8-K dated 2026-11-06 — accession 0001193125-26-451917.

FRACTYL HEALTH, INC. (GUTS) is a biotechnology company listed on US.

FRACTYL HEALTH, INC. filed a 8-K on 2026-11-06. Accession 0001193125-26-451917.

This 8-K covers: Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GUTS revenue for 2025-12-31 was $0. Net income was -$141.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. GUTS currently screens at market cap $74.9M.

Not investment advice. The GUTS SEC hub lists recent forms. The stock page is the research view.